Table 4.
Adverse events
| n (%) | PPI group | Non-PPI group | P | |
|---|---|---|---|---|
| GI bleeding | 12 (4.4) | 5 | 7 | 0.79 |
| Infection | 24 (8.8) | 8 | 16 | 0.13 |
| Stent occlusion | 41 (15.0) | 13 | 28 | 0.012 |
| Stent migration | 13 (4.7) | 10 | 3 | 0.056 |
PPI: Proton pump inhibitors, GI: Gastrointestinal
Adverse events
| n (%) | PPI group | Non-PPI group | P | |
|---|---|---|---|---|
| GI bleeding | 12 (4.4) | 5 | 7 | 0.79 |
| Infection | 24 (8.8) | 8 | 16 | 0.13 |
| Stent occlusion | 41 (15.0) | 13 | 28 | 0.012 |
| Stent migration | 13 (4.7) | 10 | 3 | 0.056 |
PPI: Proton pump inhibitors, GI: Gastrointestinal